Read about Endologix
in the news

Embrace the evidence.

The Latest:

Endologix Appoints Graham Phillips as Chief Operating Officer

See Release

All News

Archives

Endologix receives FDA Approval of the DETOUR™ System to Treat Long Complex Superficial Femoropopliteal Lesions in Patients with PAD.

Endologix Announces 150th Patient Enrolled in JAGUAR Randomized Controlled Trial

Endologix Wins “Medical Device Engineering Breakthrough” Award in 7th Annual MedTech Breakthrough Awards Program

Five-Year Results of the LEOPARD Trial published in the Journal of Vascular Surgery (JVS)

Endologix Receives FDA Approval of PMA Supplement for AFX2 System